Brean Lifts PT on Inovio Pharma (INO) to $5; Expects Strong Data from VGX-3100 Phase 2

Go back to Brean Lifts PT on Inovio Pharma (INO) to $5; Expects Strong Data from VGX-3100 Phase 2
INOVIO PHARMACEUTICALS, Inc. (NASDAQ: INO) Delayed: 1.10 -0.03 (2.65%)
Previous Close $1.13    52 Week High $11.69 
Open $1.12    52 Week Low $4.50 
Day High $1.16    P/E N/A 
Day Low $1.10    EPS $-0.28 
Volume 1,565,233